ARCHIVES

House Committee Seeks Information on ImClone Insider Stock Trading.

This article is from The Cancer Letter archive.

Vol. 28 No. 13 | March 29, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

March 15, 1991

New Grant Program in Physical Activity

March 28, 2003

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

In Brief: Rogers On AHF Board; GAO Says Legislation May Needed For Hospice Reimbursement

March 23, 1979

Charles Blanke Named Chair-Elect of SWOG

April 20, 2012